BIT’s 2nd Lung Cancer Summit - 2013

BIT s 2nd Lung Cancer Summit - 2013 covers topics such as:

• Lung Cancer Drug Discovery and Development
  • Immunotherapy and other Biotherapeutics Development
  • Molecular Target Validations, Drug Designs and Discovery Chemistry
  • Inhibiting Cell Growth
  • Anti-angiogenesis and Anti-vascular Agents
  • Gene Therapy
  • Apoptotic Inducers
• Lung Cancer Biology and Technology
  • Molecular Biology of Lung Cancer
  • Molecular Epidemiology, Pathology and Prevention
  • Molecular Profiling of Lung Cancer
  • Lung Cancer and Immunology
  • Translational Research and Clinical Trails
• NSCLC & SCLC and Interventions
  • NSCLC Stage III and Target Therapy
  • NSCLC Early Stage: Stage I and II:
  • Personalized Therapy of NSCLC
  • NSCLC Stage IV and Target Therapy
  • Small Cell Lung Cancer
  • Operable NSCLC
• Clinical Oncology, Diagnostics and Treatment
  • Lung Cancer Multimodality
  • Lung Malignancies & Metastases
  • Trend of Lung Caner Chemotherapy and Combination
  • Prognostics/Diagnostics Biomarkers
  • Imaging, Radiotherapy and Adjuvant Therapy in Lung Cancer
• Clinical Perspective, Surgery, Nursing and Palliative Care
  • Supportive Care- Tumor Pain Therapy & Nursing
  • Surgery Treatment and Lung Cancer Management
  • Palliative Care